Literature DB >> 25319715

Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.

Jharna Puppala1, Sukanya Bhrugumalla, Ajit Kumar, Siva Prasad Siddapuram, Prasad D K Viswa, Milind Kondawar, Jyothy Akka, Anjana Munshi.   

Abstract

AIM: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the world today. A previous study has suggested an association of apolipoprotein C3 (APOC3) gene variants with the risk of NAFLD in Asian Indian men living in the Western regions. The present study was carried out with an aim to evaluate the association of demographic features, serum lipid profile and APOC3 gene variants (C-482T and T-455C) NAFLD.
METHODS: One hundred and fifty NAFLD patients and 150 age and gender-matched controls were included in the study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect the genotypes of APOC3. Serum lipid profile was analyzed.
RESULTS: In the present study, body mass index was not a predictive demographic marker for NAFLD. Serum triglycerides were higher in patients (mean 155.95 ± 59.0) with NAFLD compared to the control group (mean 133.75 ± 44.71) (p = 0.016). APOC3 gene polymorphism T-455C (rs2854116) was significantly associated with NAFLD (p = 0.001). However, we did not find a significant association of C-482T polymorphism (rs2854117) of APOC3 gene with NAFLD. Genotype -455C/C of the SNP, rs2854116 associated significantly with the elevated serum triglycerides in patients.
CONCLUSIONS: The polymorphism T-455C in APOC3 gene and elevated serum triglycerides were associated with NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319715     DOI: 10.1007/s12664-014-0504-9

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  18 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.

Authors:  Jenni Hyysalo; Ivana Stojkovic; Anna Kotronen; Antti Hakkarainen; Ksenia Sevastianova; Janne Makkonen; Nina Lundbom; Aila Rissanen; Ronald M Krauss; Olle Melander; Marju Orho-Melander; Hannele Yki-Järvinen
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

3.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

4.  Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis.

Authors:  Lixin Zhu; Susan S Baker; Wensheng Liu; Meng-Hua Tao; Raza Patel; Norma J Nowak; Robert D Baker
Journal:  Metabolism       Date:  2010-11-13       Impact factor: 8.694

5.  Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4).

Authors:  S K Karathanasis; P Oettgen; I A Haddad; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

7.  The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.

Authors:  Luca Valenti; Valerio Nobili; Ahmad Al-Serri; Raffaela Rametta; Julian B S Leathart; Marco A Zappa; Paola Dongiovanni; Anna L Fracanzani; Arianna Alterio; Giancarlo Roviaro; Ann K Daly; Silvia Fargion; Christopher P Day
Journal:  J Hepatol       Date:  2011-07-21       Impact factor: 25.083

8.  Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).

Authors:  Sanjay Kalra; Manoj Vithalani; Gurjeet Gulati; C M Kulkarni; Yogesh Kadam; James Pallivathukkal; Brahmananda Das; Rakesh Sahay; K D Modi
Journal:  J Assoc Physicians India       Date:  2013-07

Review 9.  Genetics of nonalcoholic Fatty liver disease: an overview.

Authors:  Jharna Puppala; Siva Prasad Siddapuram; Jyothy Akka; Anjana Munshi
Journal:  J Genet Genomics       Date:  2012-12-26       Impact factor: 4.275

10.  Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.

Authors:  Deepa Uchil; D Pipalia; M Chawla; R Patel; Sonali Maniar; Archana Juneja
Journal:  J Assoc Physicians India       Date:  2009-03
View more
  7 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease.

Authors:  Hong-Jue Li; Chang-Ping Li; Chao Zhang; Xiao-Lin Zhong; Lei Shi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

4.  Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy.

Authors:  C Padmapriyadarsini; K Ramesh; L Sekar; Geetha Ramachandran; Devaraj Reddy; G Narendran; S Sekar; C Chandrasekar; D Anbarasu; Christine Wanke; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

5.  Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.

Authors:  Jun Wang; Chuncui Ye; Sujuan Fei
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

6.  APOC3 Gene Polymorphism and Antiretroviral Therapy-Induced Dyslipidemia in HIV-Infected Children.

Authors:  Ramalingam Srinivasan; Chandrasekaran Padmapriyadarsini; Karunaianantham Ramesh; G N Sanjeeva; Devarajulu Reddy; Elumalai Suresh; Ramesh Kumar; Pattabiraman Sathyamoorthy; Soumya Swaminathan; Anita Shet
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-26       Impact factor: 2.205

7.  Association between Genetic Variant of Apolipoprotein C3 and Incident Hypertension Stratified by Obesity and Physical Activity in Korea.

Authors:  Garam Jo; So-Young Kwak; Ji Young Kim; Hyunjung Lim; Min-Jeong Shin
Journal:  Nutrients       Date:  2018-10-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.